Trial intelligence / Profile preview

TREM-1 and TREM-2 in Periodontitis

NCT02873949Completed

Sponsor
CHRU de Nancy - Hôpital Central
Start
Apr 2016
Primary completion
Dec 2017
Countries
1
01

Overview

Open-label trial (2 arms), sponsored by CHRU de Nancy - Hôpital Central. Primary endpoint: Average concentration of soluble TREM-1 and TREM-2 in crevicular fluid at Day 0. Started Apr 2016; status: completed.

Beyond the preview

Go deeper on NCT02873949.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02873949.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call